
Eureka Forbes Q1 Results FY26: Q1 PAT Rises 20.32% to ₹38.68 Crore; Revenue Up 9.85% YoY
Q1 Results FY26
Updated: 11 Aug 2025 • 10:43 pm
Posted by:

Eureka Forbes Q1 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)
| Particulars | Quarter Ended | |
| 30-06-2025 | 30-06-2024 | |
| Revenue from Operations | ₹607.87 | ₹553.38 |
| Profit Before Tax (PBT) | ₹68.93 | ₹58.64 |
| Profit After Tax (PAT) | ₹38.68 | ₹58.64 |
(Figures in crores)
Eureka Forbes Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)
| Particulars | Quarter Ended | |
| 30-06-2025 | 30-06-2024 | |
| Revenue from Operations | ₹607.74 | ₹552.81 |
| Profit Before Tax (PBT) | ₹68.39 | ₹56.89 |
| Profit After Tax (PAT) | ₹38.52 | ₹31.04 |
(Figures in crores)
Eureka Forbes Q1 Results FY26 Highlights (Q1 FY26 vs FY25)
- Eureka Forbes clocked Q1 FY26 consolidated revenue of ₹607.87 crores vs ₹553.38 crores.
- On the profit front, Eureka Forbes earned a consolidated PAT of ₹38.68 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹32.15 crore.
- Consolidated PAT rose for the first quarter of FY26, was 20.32% YoY, and revenue rose 9.85% YoY.
- As per the standalone figures, the quarterly PAT of Eureka Forbes has increased by 24.11%, and revenue has increased by 9.94% YoY.
Eureka Forbes Share Price Performance
On the opening bell of 11th August 2025, the shares of Eureka Forbes opened at ₹560.00 per share. However, the initial gains are wiped out as of now, and Eureka Forbes shares are trading at ₹552.80 per share, higher than their opening price.
Considering the long-term performance, Eureka Forbes shares have yielded close to 9.24% returns in the past 1 year, and 5-year returns stand at 2.14%. Over the maximum timeframe, the Eureka Forbes share provided 2.14% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in Eureka Forbes shares after thorough research.
For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Recent Articles
Icodex Publishing Solutions IPO GMP: Day 1 IPO Live Updates
Bluestone Jewellery IPO GMP: Day 1 IPO Live Updates
Highway Infrastructure IPO Listing Preview: What to Expect Now in 2025?
Concord Biotech Q1 Results FY26: Q1 PAT Falls 26.07% to ₹44.06 Crore; Revenue Down 5.47% YoY
Sawaliya Foods Products IPO Allotment Status Check Online: GMP, Subscription, Price, and More
JSW Cement IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Mahendra Realtors IPO GMP & Review: Apply or Avoid?
Regaal Resources IPO GMP & Review: Apply or Avoid?
Icodex Publishing Solutions IPO GMP & Review: Apply or Avoid?
Recent Articles

Intraday Stocks for Today: HDFC Bank, Reliance and SBI – Analyst Top Picks 3 June 2026
3 June 2026

Airan Share Analyst Review: CMP, Performance, Target and 2026 Outlook
2 June 2026

DB (International) Stock Brokers Share Analyst Review: CMP, Performance, Target and 2026 Outlook
2 June 2026

Shreeji Shipping Global Share Analyst Review: CMP, Performance, Target and 2026 Outlook
2 June 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Intraday Stocks for Today: HDFC Bank, Reliance and SBI – Analyst Top Picks 3 June 2026
Airan Share Analyst Review: CMP, Performance, Target and 2026 Outlook
DB (International) Stock Brokers Share Analyst Review: CMP, Performance, Target and 2026 Outlook
Shreeji Shipping Global Share Analyst Review: CMP, Performance, Target and 2026 Outlook
Alivus Life Sciences Share Analyst Review: CMP, Performance, Target and 2026 Outlook
Popular this week
Intraday Stocks for Today: HDFC Bank, Reliance and SBI – Analyst Top Picks 3 June 2026
Airan Share Analyst Review: CMP, Performance, Target and 2026 Outlook
DB (International) Stock Brokers Share Analyst Review: CMP, Performance, Target and 2026 Outlook
Shreeji Shipping Global Share Analyst Review: CMP, Performance, Target and 2026 Outlook
Alivus Life Sciences Share Analyst Review: CMP, Performance, Target and 2026 Outlook

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





